Neuragain | Network Opportunities

Your Life, Your Practice, Your Time

There’s currently a depression epidemic…

Less than half of patients respond to the current SSRI drug treatments, creating a large unsatisfied patient population.

Many patients seek alternative therapies to treat their depression. Until now alternative choices have been limited to electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (TMS). These are insufficient for many patients and require a significant investment or hospitalization.

Now there are new advances in medicine:

Ketamine blocks neurotransmitter glutamate, which in turn stimulates synapses
Yale University study shows damage of synaptic connections caused by chronic stress is rapidly reversed by a single dose of ketamine
Our founders and providers have treated hundreds of patients using ketamine intravenous treatments for psychiatric symptoms
Ketamine infusion has shown 64% to 75% positive response rates in clinical studies, including one conducted by the NIMH

How can this benefit you?

The Neuragain opportunity integrates seamlessly into your busy practice. It typically does not require additional staffing, office space, or a significant investment in equipment, nor will it change the complexion of your practice, or tax your family time - yet it will dramatically increase your income.